BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Kinex Pharmaceuticals 

1207 Delaware Avenue

Buffalo  New York  14209  U.S.A.
Phone: 716-332-6107 Fax: 716-332-6170


SEARCH JOBS

View Clinical Trials from BioPharm Insight









 Company News
Kinex Pharmaceuticals And Zenith Technology To Initiate Clinical Studies Of An Oral Form Of Paclitaxel (Oraxol) In New Zealand 3/20/2014 10:32:47 AM    More...
Kinex Pharmaceuticals Completes Oversubscribed $40 Million Private Placement Equity Raise 3/5/2014 6:07:59 AM    More...
Kinex Pharmaceuticals And PharmaEssentia Expand Drug Development Partnership 2/6/2014 9:58:50 AM    More...
Kinex Pharmaceuticals Appoints Executives To Clinical Leadership Team 2/5/2014 9:01:59 AM    More...
Kinex Pharmaceuticals Announced That The FDA Has Granted Orphan Drug Status To KX02 For The Treatment Of Gliomas 12/4/2013 11:03:20 AM    More...
Kinex Pharmaceuticals Announces First Patient Dosed in Phase Ib Study of Oraxol, an Orally Dosed Paclitaxel 10/28/2013 11:00:24 AM    More...
Hanmi Pharmaceutical, Co., Ltd to Assign the Rights to Five New Territories to Kinex Pharmaceuticals as Part of the Orascovery Program Strategic Plan 10/22/2013 10:39:35 AM    More...
Dr. David Hangauer, Chief Scientific Officer and Co-Founder, Commits His Career to Kinex Pharmaceuticals 9/12/2013 12:34:30 PM    More...
Kinex Pharmaceuticals Receives Research Support From the Hong Kong Innovation and Technology Commission (ITC) 8/2/2013 7:44:44 AM    More...
Kinex Pharmaceuticals Announces that the US FDA Allows their IND for Oraxol, an Oral Form of Paclitaxel That is in Phase II Clinical Trials in Korea, to Begin Clinical Trials in the US 7/22/2013 11:00:49 AM    More...
1234